会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PROCESS FOR REDUCING INORGANICS FROM ANIONIC SURFACTANT SOLUTIONS
    • 从阴离子表面活性剂溶液中还原无机物的工艺
    • WO2012078521A1
    • 2012-06-14
    • PCT/US2011/063316
    • 2011-12-05
    • DOW GLOBAL TECHNOLOGIES LLCSMIT, Mark, R.DAUGS, Edward, D.COLLINS, Raymond, M.
    • SMIT, Mark, R.DAUGS, Edward, D.COLLINS, Raymond, M.
    • B01D61/02C07C303/44C07C309/09C11D1/12
    • C02F9/00B01D61/027C07C303/44C07C309/10
    • A process comprising contacting deionized water with one or more Strecker sulfonation reaction products of one or more halogenated alkyl ethers in the presence of sulfite, wherein the one or more Strecker sulfonation reaction products each comprise one or more inorganic salts on a dry basis and one or more surfactant components, form a filtration mixture; loading the filtration mixture into a high pressure filtration system containing a membrane having a membrane molecular weight cutoff allowing preferential passage of the inorganic salts, for example, of greater than or equal to 200 Daltons; wherein the high pressure filtration system is operated at a pressure greater than ambient pressure and is configured to cause crossflow of the filtration mixture along a surface of the membrane resulting in a permeate solution which substantially passes through the membrane and a retentate solution which substantially does not pass through the membrane; wherein the permeate comprises less than or equal to 15 weight percent surfactant component, based on the weight of the filtration mixture is provided.
    • 一种方法,包括在亚硫酸盐存在下使去离子水与一种或多种卤代烷基醚的一种或多种降解性磺化反应产物接触,其中所述一种或多种Strecker磺化反应产物各自包含一个或多个基于干基的无机盐, 更多的表面活性剂组分,形成过滤混合物; 将过滤混合物装入含有具有膜分子量截留的膜的高压过滤系统,允许无机盐优先通过,例如大于或等于200道尔顿; 其中所述高压过滤系统在大于环境压力的压力下操作并且被配置成使所述过滤混合物沿所述膜的表面交叉流动,导致基本上通过所述膜的渗透液和基本上不通过所述膜的渗余物溶液 通过膜; 其中所述渗透物包含基于所述过滤混合物的重量的小于或等于15重量%的表面活性剂组分。
    • 6. 发明申请
    • HYDROFORMYLATION PROCESS FOR PHARMACEUTICAL INTERMEDIATE
    • 药物中间体的水解过程
    • WO2005110986A1
    • 2005-11-24
    • PCT/US2005/014349
    • 2005-04-26
    • DOW GLOBAL TECHNOLOGIES INC.DAUGS, Edward, D.PENG, Wei-JunRAND, Cynthia, L.
    • DAUGS, Edward, D.PENG, Wei-JunRAND, Cynthia, L.
    • C07D209/48
    • C07D401/06C07D209/48C07D471/04
    • The invention relates to an improved process for the preparation of an advanced synthetic intermediate of ACE inhibitors. In one aspect, the present invention is based on a novel process for the preparation of an aldehyde of formula (I), wherein (N) PrG is a protected amino group, R is an alkyl or aralkyl group and X 1-4 are each independently H or a non-reacting substituent, which comprises hydroformylation of an α-olefin of formula (II), by reaction with syngas (CO/H 2 ) in the presence of, as catalyst, a group VIII transition metal complex of a phosphorus-containing ligand. Aldehyde (I), the product of linear hydroformylation, is formed in preference to aldehyde (III). In another aspect of the invention, α-olefin (II) is a novel composition. The process to convert (II) to (I) enables an efficient manufacturing route to MDL 28,726 and analogues.
    • 本发明涉及用于制备ACE抑制剂的高级合成中间体的改进方法。 一方面,本发明是基于制备式(I)的醛的新方法,其中(N)PrG是被保护的氨基,R是烷基或芳烷基,X <1-4> 各自独立地是H或非反应性取代基,其包括式(II)的α-烯烃的羰基化,通过在作为催化剂的催化剂存在下与合成气(CO / H 2)反应的第VIII族过渡金属络合物 含磷配体。 醛(I)是线性加氢甲酰化的产物,优选醛(III)。 在本发明的另一方面,α-烯烃(II)是一种新的组合物。 将(II)转化为(I)的过程能够实现MDL 28,726和类似物的有效制造路线。